Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-03-20 | Adele M. Gulfo ... Age 56Director since 2018 ... Ms. Gulfo ... 2018 Non-Employee Director Compensation ... Adele M. Gulfo ... Total ... 30,179 |
| 2020-03-26 | Adele M. Gulfo | Age 57 | Director since 2018 | Chief Business and Commercial Development Officer of Sumitovant Biopharma | Yes ... Committee memberships ... M ... M ... M ... Ms. Gulfo has served as the Chief Business and Commercial Development Officer at Sumitovant Biopharma since December 2019. |
| 2021-03-26 | Adele M. Gulfo | Age 58 | Director since 2018 ... the board currently includes two female directors ... 2020 Non-Employee Director Compensation ... Adele M. Gulfo ... Total ($) 200,221 |
| 2022-03-25 | Adele M. Gulfo ... Age 59 ... Director since 2018 ... all of our independent directors serve on each committee other than the Executive Committee. ... the board determined that Ms. Gulfo ... are independent. ... Total ($) 200,962 |
| 2023-03-24 | Adele M. Gulfo ... Chief Business and Commercial Development Officer of Sumitovant Biopharma ... Age 60 ... committee memberships ... AC, CC, NC ... 2022 Non-Employee Director Compensation ... Adele M. Gulfo ... Total ($) 207,199 |
| 2024-03-25 | Adele M. Gulfo ... Age 61 ... the board determined that Ms. Gulfo ... are independent ... two female directors ... 2023 Non-Employee Director Compensation ... Total ($) 204,614 |
| 2025-03-24 | Adele M. Gulfo ... Age 62 ... Director since 2018 ... Adele M. Gulfo ... 2024 Non-Employee Director Compensation ... Total 237,361 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-07-06